CITIUS ONCOLOGY INC (CTOR:NASDAQ)
$0.691 -0.0303 (-4.2007%)
Analysed CITIUS ONCOLOGY INC (CTOR:NASDAQ) News Sources
Citius Oncology Provides Commercial Update on LYMPHIR™ Launch Highlighting Early Adoption and Expanding Clinical Development
31-03-2026
yahoo.com
Breakeven On The Horizon For Citius Oncology, Inc. (NASDAQ:CTOR)
15-04-2026
yahoo.com
Citius Oncology Ships First International Order of LYMPHIR™ to Europe
29-04-2026
yahoo.com
Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization
06-05-2026
yahoo.com
Citius raises $36.5m for Lymphir commercialisation
06-05-2026
pharmaceutical-technology.com
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
15-05-2026
yahoo.com
Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
15-05-2026
yahoo.com
Is Citius Pharmaceuticals, Inc. (CTXR) among the Best Rated Penny Stocks to Buy According to Wall Street Analysts?
24-05-2026
yahoo.com
Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
26-05-2026
yahoo.com
Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies
01-06-2026
yahoo.com
What is the current price of CITIUS ONCOLOGY INC (CTOR:NASDAQ)?
The current price of CITIUS ONCOLOGY INC (CTOR:NASDAQ) is $0.691.
CITIUS ONCOLOGY INC (CTOR:NASDAQ) absolute price change since previous trading day?
The absolute price change of CITIUS ONCOLOGY INC (CTOR:NASDAQ) since the previous trading day is $-0.0303.
CITIUS ONCOLOGY INC (CTOR:NASDAQ) percentage price change since previous trading day?
The percentage price change of CITIUS ONCOLOGY INC (CTOR:NASDAQ) since the previous trading day is -4.2007%.
What is the most recent average sentiment score for CITIUS ONCOLOGY INC (CTOR:NASDAQ)?
The most recent average sentiment score for CITIUS ONCOLOGY INC (CTOR:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for CITIUS ONCOLOGY INC (CTOR:NASDAQ)?
The most recent sentiment for CITIUS ONCOLOGY INC (CTOR:NASDAQ) is .
SEC-8K** Filing Available For CITIUS ONCOLOGY INC (CTOR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.